The activity assay illustrated that all of the samples analysed contained physiologically active ADAM17 however there was no significant difference in the amount of enzyme activity between JSLE CD14+ cells and those from JIA or control patients. The gene discussed is CD14; the disease is juvenile idiopathic arthritis.